Trump's Endorsement A Double-Edged Sword For Regeneron

President Trump's touting of Regeneron's COVID-19 treatment boosted the stock, but also added an element of political risk to it. We elaborate and show how cautious bulls can stay long while strictly limiting their risk.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.